09/09/2025
Russia’s experimental mRNA-based cancer vaccine, Enteromix, has demonstrated 100% efficacy and safety in early trials, particularly against colorectal cancer. It is designed to shrink tumors, slow their growth, and train the immune system to eliminate cancer cells—without the severe side effects of chemotherapy or radiation. Developed by Russian scientists, the personalized vaccine is now awaiting regulatory approval after its promising initial results.
